4-Fluoro-N-piperidin-3-ylmethyl-benzenesulfonamide hydrochloride, 95.0%, 250mg

(2R,5S)-1-(tert-Butoxycarbonyl)-5-phenylpyrrolidine-2-carboxylic acid, 95.0%, 100mg

(2E,4E)-Hexa-2,4-dien-1-ol, 97%, 25g

7-(Diethylamino)-4-(trifluoromethyl)coumarin>98.0%(GC)200mg

3-Boc-Amino-2,6-dioxopiperidine, 95.0%, 25g

1-{[3-(trifluoromethyl)phenyl]methyl}-1,4-diazepane, 95.0%, 1g

5-Bromo-6-methoxypicolinic acid, 95.0%, 5g

2-(9,10-Di(naphthalen-2-yl)anthracen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 25g

Sample vials, 10 ml, 100 Piece(s)

(1-(METHYLSULFONYL)PIPERIDIN-4-YL)METHANOL, 95.0%, 5g

(5-Ethoxy-2-fluorophenyl)boronic acid, 95.0%, 25g

1-Ethylpyrrolidin-3-ol, 97.0%, 100g

tert-Butyl 1-amino-3-azabicyclo[3.2.1]octane-3-carboxylate, 97%, 100mg